Page last updated: 2024-10-21

acemetacin and Orthopedic Disorders

acemetacin has been researched along with Orthopedic Disorders in 1 studies

acemetacin : A carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation. Its activity is due to both acemetacin and its major metabolite, indometacin.

Research Excerpts

ExcerptRelevanceReference
" In this post hoc analysis of a prospective, one-arm clinical study of a short-term treatment with acemetacin, a total of 406 patients with pain because of various musculoskeletal diseases with or without joint inflammation was evaluated for the influence of body mass index (BMI) on the reduction of pain at rest, pain at movement and for mobility restriction between visits one and three (primary outcome parameters)."9.12Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases. ( Dejaco, C; Duftner, C; Schirmer, M, 2007)
" In this post hoc analysis of a prospective, one-arm clinical study of a short-term treatment with acemetacin, a total of 406 patients with pain because of various musculoskeletal diseases with or without joint inflammation was evaluated for the influence of body mass index (BMI) on the reduction of pain at rest, pain at movement and for mobility restriction between visits one and three (primary outcome parameters)."5.12Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases. ( Dejaco, C; Duftner, C; Schirmer, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dejaco, C1
Duftner, C1
Schirmer, M1

Trials

1 trial available for acemetacin and Orthopedic Disorders

ArticleYear
Lack of influence of body mass index on efficacy and tolerance of acemetacin in short-term treatment of musculoskeletal diseases.
    Rheumatology international, 2007, Volume: 27, Issue:4

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Body Mass Index; Dose-Response Relationship, D

2007